ASH Coagulation Presentation Overview

The 67th ASH Annual Meeting is December 6–9 in Orlando, FL, USA. Here’s Dr. Wolfgang Miesback’s list of bleeding disorder presentations.

Comments (0)

Bleeding Disorders

Oct 29 2025

george

Gene Transfer Therapy Updates

Yesterday, 10-28-25, we reported BioMarin’s press release announcing divestiture of their hemophilia A gene transfer therapy, valoctocogene roxaparvovec (Roctavian®). Previously, on February 25, 2025, Pfizer announced their intention to discontinue hemophilia B gene transfer therapy, fidanacogene elaparvovec-dzkt (Becvez®). Press releases from both indicate underperformance in sales. The remaining hemophilia B therapy, etranacogene dezaparvovec-drlb (HEMGENIX®), CSL […]

Bleeding Disorders

BioMarin Plans to Divest Struggling Gene Therapy

Thanks to Dean Willett of Precision BioLogic Inc. for the heads-up on BioMarin’s 10-27-25 post announcing their divestment of the hemophilia A gene transfer therapy, Roctavian. See BioMarin’s 10-27 press release.

Bleeding Disorders

A Coag Conversation: Alternate Warfarin Monitoring When the Prothrombin Time is Unreliable – Part 1

Join me (Geo) and guest speaker Dr. Nicole Zantek, MD, PhD, Medical Director of the Special Coagulation Laboratory, Professor, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, who discusses the pathophysiology of antiphospholipid antibodies, and alternative methods to monitor warfarin and DOAC anticoagulation in patients diagnosed with antiphospholipid syndrome. This is the […]

Comments (0)

Anticoagulant Therapy

Jun 28 2025

george

Differential Discussion: Hemophilia Part 2

On June 6, 2025, Malissa Norfolk and Dave Cabral posted George’s audio PowerPoint, “Have We Cured Hemophilia, Part 1?.” On June 25, Malissa and Dave posted “Have We Cured Hemophilia, Part 2?” Each video is 30″ long. Please feel free to watch and comment below.

Bleeding Disorders

Invent-VTE

In the ISTH annual meeting (June 21–25, 2025) I (Geo) met a representative of Invent-VTE, a non-profit dedicated to fostering international VTE research collaboration. Navigate to Hemostasis Agencies to see Invent-VTE‘s website and our complete list of hemostasis-related agencies.

Events

Webinar Summarizes ISLH Meeting 7–9 May, 2025

Click here to see our Precision BioLogic Inc. webinar summarizing our activities at the 7–9 May ISLH meeting in Halifax, NS, featuring PBI scientific staff Jon Geske, Ian Burns, Stephanie Henneberry, Mushfigur Rahman, and Tara Quinton. I (Geo) added a presentation describing the NASCOLA meeting. NASCOLA typically schedules its annual meeting to coincide with major […]

Events

Rutgers University Advanced Hemostasis Course

Thank you to Dr. Deborah Josko for her catalog description of Rutgers’ Medical Laboratory Science program CLSC 5124 Advanced Hemostasis Course, This graduate course is offered during the fall academic term for master’s and doctoral-level students. Any certified MLS/MLT professional may attend. This includes those who are not currently matriculated into Rutgers’ graduate programs who […]

Events

FVIII-Depleted Reagent Plasma With and Without VWF

The poster, Henneberry S, Rahman M,Wood A, Notini KM, Black KM, Sadeghi-Khomami A. Comparative analysis of commercial factor VIII (FVIII) deficient plasmas with and without von Willebrand factor for FVIII one-stage clotting assay (OSA) was presented on Thursday, 8 May 2025 at the ISLH meeting in Halifax, NS. Click here to see the poster.

Bleeding Disorders

What is NASCOLA?

I (Geo) enjoyed dining with our NASCOLA colleagues on Wednesday, 7 May 2025, while attending the 2025 ISLH annual meeting in Halifax, NS. NASCOLA is a nonprofit organization that provides proficiency testing services for North American laboratories that perform diagnostic testing for bleeding or thrombotic disorders, thereby improving performance standards. NASCOLA reviews and assists with […]

Comments (0)

Validation

Events

ASH Coagulation Presentation Overview

Gene Transfer Therapy Updates

BioMarin Plans to Divest Struggling Gene Therapy

A Coag Conversation: Alternate Warfarin Monitoring When the Prothrombin Time is Unreliable – Part 1

Differential Discussion: Hemophilia Part 2

Invent-VTE

Webinar Summarizes ISLH Meeting 7–9 May, 2025

Rutgers University Advanced Hemostasis Course

FVIII-Depleted Reagent Plasma With and Without VWF

What is NASCOLA?

George Fritsma MS MLS

Cheat Sheets from George

Questions or Comments?

Quick Question